Literature DB >> 22301671

Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review.

Madelon van Wely1, Irene Kwan, Anna L Burt, Jane Thomas, Andy Vail, Fulco Van der Veen, Hesham G Al-Inany.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22301671     DOI： 10.1093/humupd/dmr048

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN： 1355-4786            Impact factor:   15.610


× No keyword cloud information.
  8 in total

1.  Use of various gonadotropin and biosimilar formulations for in vitro fertilization cycles: results of a worldwide Web-based survey.

Authors:  Mindy S Christianson; Gon Shoham; Kyle J Tobler; Yulian Zhao; Brent Monseur; Milton Leong; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2017-06-01       Impact factor: 3.412

2.  Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.

Authors:  Alberto Revelli; Grazia Pettinau; Gemma Basso; Andrea Carosso; Alessandro Ferrero; Cecilia Dallan; Stefano Canosa; Gianluca Gennarelli; Daniela Guidetti; Claudia Filippini; Chiara Benedetto
Journal:  Reprod Biol Endocrinol       Date:  2015-07-25       Impact factor: 5.211

Review 3.  FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis.

Authors:  D Santi; A R M Granata; M Simoni
Journal:  Endocr Connect       Date:  2015-06-25       Impact factor: 3.335

4.  Comparative gene expression profiling in human cumulus cells according to ovarian gonadotropin treatments.

Authors:  Said Assou; Delphine Haouzi; Hervé Dechaud; Anna Gala; Alice Ferrières; Samir Hamamah
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

Review 5.  Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.

Authors:  Rogério de Barros F Leão; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

6.  Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only.

Authors:  Ahter Tanay Tayyar; Semra Kahraman
Journal:  Arch Med Sci       Date:  2018-01-08       Impact factor: 3.318

Review 7.  Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation.

Authors:  P E Levi Setti; C Alviggi; G L Colombo; C Pisanelli; C Ripellino; S Longobardi; P L Canonico; G De Placido
Journal:  J Endocrinol Invest       Date:  2014-12-06       Impact factor: 4.256

8.  Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison.

Authors:  Zhisong Ji; Xiaozhen Quan; Yanli Lan; Meng Zhao; Xiaolong Tian; Xuezhou Yang
Journal:  Curr Ther Res Clin Exp       Date:  2019-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.